Modulation of cerebral malaria by curcumin as an adjunctive therapy
AUTOR(ES)
Jain, Kunal, Sood, Sumeet, Gowthamarajan, K.
FONTE
Braz J Infect Dis
DATA DE PUBLICAÇÃO
2013-10
RESUMO
Cerebral malaria is the most severe and rapidly fatal neurological complication of Plasmodium falciparum infection and responsible for more than two million deaths annually. The current therapy is inadequate in terms of reducing mortality or post-treatment symptoms such as neurological and cognitive deficits. The pathophysiology of cerebral malaria is quite complex and offers a variety of targets which remain to be exploited for better therapeutic outcome. The present review discusses on the pathophysiology of cerebral malaria with particular emphasis on scope and promises of curcumin as an adjunctive therapy to improve survival and overcome neurological deficits.
Documentos Relacionados
- Vascular dysfunction as a target for adjuvant therapy in cerebral malaria
- Radiographic assessment of photodynamic therapy as an adjunctive treatment on induced periodontitis in immunosuppressed rats
- Efficacy of Carisolv™ as an adjunctive therapy to scaling and root planing on subgingival calculus removal
- Intramyocardial injection of autologous bone marrow cells as an adjunctive therapy to incomplete myocardial revascularization: safety issues
- Omega-3 fatty acid supplementation as an adjunctive therapy in the treatment of chronic kidney disease: a meta-analysis